P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETINGConstantin Schmidt, Sascha Dietrich, Peter‐Martin Bruch et al.|HemaSphere|2022Cited by 0